Geneva, January 5, 2026 – The International Generic and Biosimilar Medicines Association (IGBA), which represents global manufacturers of generic and biosimilar medicines, announced today that Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA) and Biosimilars Canada, has assumed the role of IGBA Chair for 2026. He succeeds Shinichiro Hirose, Director of International Affairs at the Japan Generic Medicines Association (JGA).
